Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trastuzumab, Ixabepilone, and Carboplatin in HER2+ Metastatic Breast Cancer
NCT00077376Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Mar 2005
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ixabepilone in breast cancer, sponsored by National Cancer Institute. Started Mar 2005; status: completed.
02
Drugs
ixabepilone
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00077376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00077376.